TEAD1 has been found either upregulated, for instance in prostatic or pancreatic cancers [33], [34], or conversely decreased in bladder or breast cancer, for example (as reported by the ONCOMINE database [35], [36], [37]). This evidence concerns the gene TEAD1 and familial pancreatic carcinoma.